About Niche Biopharmaceuticals
Niche Biopharmaceuticals is a private company based in Shorewood, Minnesota. It has reported $525,000 raised in four offerings on Form D since February 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | May 11, 2026 | $200,000fully sold | 4 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Apr 30, 2025 | May 9, 2025 | $100,000fully sold | 2 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Jan 20, 2023 | Feb 6, 2023 | $200,000fully sold | 5 | $40,000 | EquityRule 506(b) | Form D ↗ |
| Feb 2, 2021 | Feb 17, 2021 | $25,000of $310K target | 1 | $25,000 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $525,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Niche Biopharmaceuticals's Form D filed May 11, 2026.
DS
Daniel Saccani
Chief Financial Officer and director
PS
Patrick Schlievert
CSO, Co-founder and director
RK
Robert Klem
Director
DR
PB
Paul Brennan
Board Member